Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.6.0.2
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2016
Dec. 31, 2015
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 49,750 $ 55,143
Trading account assets, pledged as collateral 106,057 107,776
Debt securities:    
Carried at fair value, pledged as collateral 29,804 29,810
Held-to-maturity, fair value 115,285 84,046
Held-to-maturity, pledged as collateral 8,233 9,074
Loans and leases, measured at fair value 7,085 6,938
Loans and leases, pledged as collateral 31,805 37,767
Loans held-for-sale, measured at fair value 4,026 4,818
Other assets, measured at fair value 13,802 14,320
Deposits in U.S. offices:    
Interest-bearing, measured at fair value 731 1,116
Federal funds purchased and securities loaned or sold under agreements to repurchase, measured at fair value 35,766 24,574
Short-term borrowings, measured at fair value 2,024 1,325
Accrued expenses and other liabilities, measured at fair value 14,630 13,899
Accrued expenses and other liabilities, reserve for unfunded lending commitments 762 646
Long-term debt, measured at fair value $ 30,037 $ 30,097
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 3,887,329 3,767,790
Preferred stock outstanding (in shares) 3,887,329 3,767,790
Common stock par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 10,052,625,604 10,380,265,063
Common stock outstanding (in shares) 10,052,625,604 10,380,265,063
Consolidated VIEs | Long-term debt    
Shareholders’ equity    
Non-recourse debt $ 10,417 $ 11,304
Consolidated VIEs | Other liabilities    
Shareholders’ equity    
Non-recourse debt $ 38 $ 20